GEMMABio is a therapeutics company that develops gene therapies for individuals living with rare diseases.
GEMMABio has raised $34.0M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
GEMMABio's investors include Earlybird Venture Capital, Bioluminescence Ventures, Double Point Ventures, Savanne Life Sciences.
GEMMABio is headquartered in Philadelphia, United States.
GEMMABio is a therapeutics company that develops gene therapies for individuals living with rare diseases.
GEMMABio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GEMMABio — Funding & Investors." VCBacked, December 23, 2024, https://www.vcbacked.co/company/gemmabio. Accessed November 12, 2026.
VCBacked. (2024). GEMMABio — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/gemmabio
{{cite web |title=GEMMABio — Funding & Investors |url=https://www.vcbacked.co/company/gemmabio |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at GEMMABio? Request a listing update